Leptin and adiponectin are both involved in signaling pathways important in cancer and Alzheimer’s disease; these pathways tend to decrease cancer risk (except for childhood leukemia) and to increase Alzheimer’s disease risk, supporting the observation that excess body fat is a risk factor for both cancer and Alzheimer’s disease. The gene discussed is LEP; the disease is cancer.